Scott Segal serves as Executive at Protea Biosciences Group, Inc., where they oversee executive responsibilities. Since joining the company, Scott Segal has executed 8 insider transactions totaling $588.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 24, 2017 involved transacting 1,000,000 shares valued at $0.
Scott Segal currently holds 3,633,844 shares of Protea Biosciences Group, Inc. (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Segal has been a net buyer of NONE stock. They have purchased $588.0K and sold $0 worth of shares.
Scott Segal's most recent insider trade was on Mar 24, 2017, when they sold 1,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 31, 2015 | PRGB | $0 | Other | 10,464 | $N/A | Discretionary |
| Mar 31, 2015 | PRGB | $0 | Other | 418,552 | $N/A | Discretionary |
| Jul 23, 2013 | NONE | $194.0K | Purchase | 388,038 | $0.50 | Discretionary |
| Jul 23, 2013 | NONE | $194.0K | Purchase | 388,038 | $0.50 | Discretionary |
| Dec 27, 2011 | NONE | $100.0K | Purchase | 50,000 | $2.00 | Discretionary |
| Dec 27, 2011 | NONE | $100.0K | Purchase | 50,000 | $2.00 | Discretionary |